Immunohistochemical staining of RLS40 tumor sections with PCNA-specific primary antibodies demonstrated that 61.1 ± 1.9% and 76.3 ± 3.2% of tumor cells were PCNA-positive in the control and μ-Scr-ON groups, respectively (Figure 6e,f). Here, PCNA is linked to neoplasm.